Spotlight Presentation: The Future of Biologics Drug Product: High-Concentration, Device-Led and Patient-Centric

09 Mar 2027
CMC Strategy & Regulatory Readiness , AI, Automation & Digital Manufacturing , Upstream Process Development & Optimisation , Downstream Processing & Manufacturing Innovation , Drug Product Development & Formulation

• High-concentration and device-led subcutaneous delivery
• Sterile manufacturing under tighter European requirements
• Sustainability across packaging, cold chain and supply